Kazam Joshua A has filed 5 insider transactions across 1 company since June 2023.
Most recent transaction: a option exercise of 47700 shares of Allogene Therapeutics, Inc. ($ALLO) on December 18, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 18, 2025 | Allogene Therapeutics, Inc. | $ALLO | Kazam Joshua A | Director | M | Common Stock | 47700 | $0.00 | 350,763.0000 | 224,730,144 | 15.74% | 0.02% |
| Dec. 18, 2025 | Allogene Therapeutics, Inc. | $ALLO | Kazam Joshua A | Director | M | Restricted Stock Unit | 47700 | $0.00 | 47,700.0000 | 224,730,144 | 50.00% | 0.02% |
| June 18, 2025 | Allogene Therapeutics, Inc. | $ALLO | Kazam Joshua A | Director | A | Restricted Stock Unit | 94500 | $0.00 | 94,500.0000 | 217,264,738 | 9999.99% | 0.04% |
| June 5, 2024 | Allogene Therapeutics, Inc. | $ALLO | Kazam Joshua A | Not found | A | Stock Option (Right to buy) | 191082 | $0.00 | 191,082.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2023 | Allogene Therapeutics, Inc. | $ALLO | Kazam Joshua A | Not found | A | Stock Option (Right to Buy) | 116120 | $0.00 | 116,120.0000 | 0 | 9999.99% | 0.00% |